+62.6%
GSK vs CNH
+7.0%
+55.6%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CNH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +2.8% | -2.9% | -0.5% |
| 7D | +1.7% | -1.7% | +3.4% | +1.8% |
| 30D | +7.0% | -7.2% | +14.3% | +7.8% |
| 3M | -2.7% | +6.5% | -9.2% | -3.6% |
| 6M | +1.4% | +7.9% | -6.4% | 0.0% |
| YTD | +5.3% | +26.6% | -21.2% | +2.8% |
| 1Y | +10.6% | +13.8% | -3.1% | +8.6% |
| 3Y | +62.6% | +9.2% | +53.4% | +59.4% |
| All | +62.6% | +7.0% | +55.6% | +59.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CNH.
Daily Out/Under-Performance
Portfolio return minus CNH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CNH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CNH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling